Professional Seasonal Analysis for Trading

Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

Seasonality Analysis

Stocks 7 Years Analyzed

Phathom Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

31.31%
Avg Annual Return
52.4%
Avg Monthly Win Rate
8/12
Positive Months
7
Years Analyzed

Phathom Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -7.04%
29%
Very Weak
February 6.64%
57%
Moderate
March -10.90%
14%
Very Weak
April 8.32%
57%
Moderate
May 1.83%
67%
Strong
June BEST 19.83%
50%
Weak
July 2.69%
67%
Strong
August 16.49%
67%
Strong
September 0.41%
50%
Weak
October -1.99%
57%
Weak
November WORST -11.62%
43%
Weak
December 6.65%
71%
Very Strong

Phathom Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
34.16
Historical Avg Position
38.1
Deviation
-3.93
Performance
On Track

Phathom Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for PHAT with overlay patterns, custom date ranges, and more.

Create Free Account

Phathom Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Phathom Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for PHAT across multiple timeframes.

Create Free Account

About Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) Seasonality

Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) has been analyzed using 7 years of historical data to identify seasonal patterns. Classified under Stocks, Phathom Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Phathom Pharmaceuticals, Inc. - Common Stock is historically June, with an average return of 19.83% and a win rate of 50%. Conversely, November tends to be the weakest month, averaging -11.62% return.

Looking at the full calendar year, Phathom Pharmaceuticals, Inc. - Common Stock has an average annual return of 31.31% with an overall monthly win rate of 52.4%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Phathom Pharmaceuticals, Inc. - Common Stock has a consistency score of 51.3 (Fair), based on 8 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Phathom Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)?

Historically, June has been the best month for Phathom Pharmaceuticals, Inc. - Common Stock, with an average return of 19.83% and a win rate of 50%. However, past performance does not guarantee future results.

What is the worst month for Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)?

Based on historical data, November has been the weakest month for Phathom Pharmaceuticals, Inc. - Common Stock, with an average return of -11.62%. This is a historical observation and does not guarantee future results.

How reliable is PHAT seasonality data?

The seasonality analysis for Phathom Pharmaceuticals, Inc. - Common Stock is based on 7 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Phathom Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.